Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 9c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of ($1.10), $0.09 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
• JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral